Stock Research for ANGO

ANGO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ANGO Stock Chart & Research Data

The ANGO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANGO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ANGO Due diligence Resources & Stock Charts

The ANGO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ANGO Detailed Price Forecast - CNN Money CNN View ANGO Detailed Summary - Google Finance
Yahoo View ANGO Detailed Summary - Yahoo! Finance Zacks View ANGO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ANGO Trends & Analysis - Trade-Ideas Barrons View ANGO Major Holders - Barrons
NASDAQ View ANGO Call Transcripts - NASDAQ Seeking View ANGO Breaking News & Analysis - Seeking Alpha
Spotlight View ANGO Annual Report - CompanySpotlight.com OTC Report View ANGO OTC Short Report - OTCShortReport.com
TradeKing View ANGO Fundamentals - TradeKing Charts View ANGO SEC Filings - Bar Chart
WSJ View Historical Prices for ANGO - The WSJ Morningstar View Performance/Total Return for ANGO - Morningstar
MarketWatch View the Analyst Estimates for ANGO - MarketWatch CNBC View the Earnings History for ANGO - CNBC
StockMarketWatch View the ANGO Earnings - StockMarketWatch MacroAxis View ANGO Buy or Sell Recommendations - MacroAxis
Bullish View the ANGO Bullish Patterns - American Bulls Short Pains View ANGO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ANGO Stock Mentions - StockTwits PennyStocks View ANGO Stock Mentions - PennyStockTweets
Twitter View ANGO Stock Mentions - Twitter Invest Hub View ANGO Investment Forum News - Investor Hub
Yahoo View ANGO Stock Mentions - Yahoo! Message Board Seeking Alpha View ANGO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ANGO - SECform4.com Insider Cow View Insider Transactions for ANGO - Insider Cow
CNBC View ANGO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ANGO - OTC Markets
Yahoo View Insider Transactions for ANGO - Yahoo! Finance NASDAQ View Institutional Holdings for ANGO - NASDAQ


Stock Charts

FinViz View ANGO Stock Insight & Charts - FinViz.com StockCharts View ANGO Investment Charts - StockCharts.com
BarChart View ANGO Stock Overview & Charts - BarChart Trading View View ANGO User Generated Charts - Trading View




Latest Financial News for ANGO


AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
Posted on Monday May 06, 2024

LATHAM, N.Y., May 06, 2024--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that results from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV) were presented at The Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions hosted in L


Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks
Posted on Wednesday May 01, 2024

After some recent losses, markets turned up on Wednesday, coinciding with Federal Reserve Chair Jay Powell’s announcement confirming that there will be no further rate hikes for the foreseeable future. The upward turn in the markets highlights the volatility in current conditions – but that’s not a bad thing at all, for at least one market expert. John Stoltzfus, chief investment strategist at Oppenheimer, gives a clear explanation of where the market stands now: “Some near-term profit-taking in


Insider Spends US$67k Buying More Shares In AngioDynamics
Posted on Wednesday April 10, 2024

Even if it's not a huge purchase, we think it was good to see that James Clemmer, the CEO, President & Director of...


AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
Posted on Monday April 08, 2024

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript April 4, 2024 AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.